WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+17.78%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$9.17B
AUM Growth
+$646M
(+7.6%)
Cap. Flow
-$132M
Cap. Flow
% of AUM
-1.44%
Top 10 Holdings %
Top 10 Hldgs %
15.24%
Holding
726
New
146
Increased
136
Reduced
152
Closed
261
Top Buys
| 1 |
TE Connectivity
TEL
|
$118M |
| 2 |
Ovintiv
OVV
|
$108M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$106M |
| 4 |
Amazon
AMZN
|
$86M |
| 5 |
Qorvo
QRVO
|
$80.1M |
Top Sells
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
$238M |
| 2 |
Electronic Arts
EA
|
$107M |
| 3 |
Autodesk
ADSK
|
$95.8M |
| 4 |
Keysight
KEYS
|
$88.3M |
| 5 |
STMicroelectronics
STM
|
$82.2M |
Sector Composition
| 1 | Healthcare | 41.58% |
| 2 | Technology | 23.85% |
| 3 | Industrials | 10.4% |
| 4 | Energy | 8.49% |
| 5 | Consumer Discretionary | 6.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Phathom Pharmaceuticals
PHAT
$851M
| $10M | 0.11% |
1,096,121
+356,100
| +48% | +$3.25M |
|
227
Endava
DAVA
$593M
| $9.96M | 0.11% |
127,931
| – | – |
|
|
VRNA
228
Verona Pharma
VRNA
$9.19B
| $9.96M | 0.11% |
500,965
-85,757
| -15% | -$1.7M |
|
229
Immunome
IMNM
$853M
| $9.87M | 0.11% |
+922,892
| New | +$9.87M |
|
230
Waste Connections
WCN
$46.6B
| $9.8M | 0.11% |
65,667
+16,870
| +35% | +$2.52M |
|
231
Restaurant Brands International
QSR
$20.4B
| $9.61M | 0.1% |
123,045
+26,004
| +27% | +$2.03M |
|
232
Pinterest
PINS
$25.2B
| $9.42M | 0.1% |
254,300
-1,555,136
| -86% | -$57.6M |
|
|
ANSS
233
DELISTED
Ansys
ANSS
| $9.41M | 0.1% |
25,922
-75,984
| -75% | -$27.6M |
|
234
Jack in the Box
JACK
$367M
| $9.33M | 0.1% |
+114,256
| New | +$9.33M |
|
235
EyePoint Pharmaceuticals
EYPT
$819M
| $9.24M | 0.1% |
+400,000
| New | +$9.24M |
|
236
Ferguson
FERG
$47.8B
| $9.11M | 0.1% |
+47,209
| New | +$9.11M |
|
237
Apogee Therapeutics
APGE
$2.21B
| $9.11M | 0.1% |
326,102
+16,102
| +5% | +$450K |
|
238
Annexon
ANNX
$236M
| $9.08M | 0.1% |
2,000,000
+535,635
| +37% | +$2.43M |
|
239
Editas Medicine
EDIT
$227M
| $9.07M | 0.1% |
895,401
-2,364,309
| -73% | -$24M |
|
240
Xenon Pharmaceuticals
XENE
$2.98B
| $9.05M | 0.1% |
196,453
+53,002
| +37% | +$2.44M |
|
241
Estee Lauder
EL
$31.5B
| $8.83M | 0.1% |
+60,359
| New | +$8.83M |
|
|
CERE
242
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $8.73M | 0.09% |
205,809
-270,825
| -57% | -$11.5M |
|
|
MRNS
243
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $8.7M | 0.09% |
800,000
+168,480
| +27% | +$1.83M |
|
244
e.l.f. Beauty
ELF
$7.59B
| $8.67M | 0.09% |
60,070
-96,559
| -62% | -$13.9M |
|
245
Vestis
VSTS
$595M
| $8.54M | 0.09% |
+403,770
| New | +$8.54M |
|
|
SMAR
246
DELISTED
Smartsheet Inc.
SMAR
| $8.39M | 0.09% |
+175,362
| New | +$8.39M |
|
|
TXNM
247
TXNM Energy, Inc.
TXNM
$5.99B
| $8.32M | 0.09% |
200,004
-128,968
| -39% | -$5.37M |
|
248
Allogene Therapeutics
ALLO
$246M
| $8.27M | 0.09% |
2,577,500
-2,736,415
| -51% | -$8.78M |
|
249
CyberArk
CYBR
$23.1B
| $8.23M | 0.09% |
37,563
-14,368
| -28% | -$3.15M |
|
250
ITT
ITT
$13.4B
| $8.19M | 0.09% |
+68,616
| New | +$8.19M |
|